Strategic Advisory
Advising life science companies and investors on IP strategy, company positioning, capital strategy, and transaction readiness at critical inflection points.
Advising life science companies, investors, and boards on IP strategy, company positioning, capital raising, and transaction readiness at critical inflection points
I advise biotech and health innovation companies on how to position themselves for investment, partnerships, and growth. I combine deep IP and scientific understanding with strategic and commercial insight, enabling clients to strengthen their equity story and maximize long-term value. I work closely with founders, boards, and investors at pivotal stages of company development.
I work with companies at the moments that matter most - when the right strategic choices define long-term value.
read more about approachAdvising life science companies and investors on IP strategy, company positioning, capital strategy, and transaction readiness at critical inflection points.
Serving as board member, chair, or strategic advisor to leadership teams, providing experienced guidance on governance, strategy, and value creation.
Advising venture funds on deal sourcing, due diligence, IP evaluation, and portfolio company strategy.
Delivering talks, moderating panels, and contributing to strategic discussions on life science innovation, leadership, and diversity in the sector.
Book a meeting with me and let’s explore how we can work together.
book a callA strong sense of responsibility underpins every engagement. I provide honest, independent advice-even when it is challenging-and take ownership of the quality and impact of the work I deliver.
Decisions in life sciences shape value over many years. The focus is not on short-term optimization, but on building sustainable positions-scientifically, strategically, and financially.
Complex science requires clear strategic choices. Lene supports leadership teams in defining priorities, evaluating trade-offs, and making decisions that stand up to investor, partner, and board scrutiny.
Capital is a critical resource. A disciplined approach ensures that financing strategies, resource allocation, and development plans are aligned to maximize long-term value creation.
Value in life sciences is often realized through partnerships. The approach emphasizes positioning, credibility, and alignment-ensuring companies are prepared to engage with investors, pharma, and other stakeholders from a position of strength.
Alexandra Hoegberg - March 7, 2026
read more
Nordic Life Science
read more
Alexandra Hoegberg - March 7, 2026
read more
Alexandra Hoegberg - March 7, 2026
read moreBoard member in 23 life science companies, including 18 roles as chairperson. Extensive experience in governance, strategic oversight, and guiding companies through critical value-creating decisions.
12 years of experience as an investor in venture capital funds, with deep involvement in evaluating life science opportunities, portfolio strategy, and value creation.
European Patent Attorney with extensive experience in IP strategy, patent portfolio development, and the role of IP in transactions, financing, and company positioning.
Co-founder, Chair & Executive CEO WiLD Denmark. Driving strategic initiatives, partnerships, and cross-Nordic collaboration across Denmark, Norway, and Finland.
scroll sideways
Name
This section will showcase selected client testimonials, presented in a dynamic, rotating slider. Each story highlights the impact of our collaboration, offering insight into how we support clients in making confident, high-stakes decisions and achieving meaningful, long-term results.
Discover My LinkedIn Profile & Follow to stay updated
LinkedIn ProfileLet’s connect, book a meeting and discover how we can work together.
lene.gerlach@gmail.com +45 20 31 74 60If you prefer, feel free to fill out the form.